Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $6.49 Analyst target: $33.67 Upside: 418.80%
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company is headquartered in Watertown, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.